Skip to main content
Premium Trial:

Request an Annual Quote

Beckman's Q2 Sales Miss Target as Profits Fall 20 Percent

NEW YORK (GenomeWeb News) — Beckman Coulter today reported a slight decrease in second-quarter sales accompanied by a 19-percent drop in net income.
 
Total receipts for the three months ended June 30 declined to $616.3 million, from $618.8 in the same period last year. Beckman had initially forecast revenues to be between $620 million and $645 million, and the company blamed the lower-than-expected revenues on lagging sales in the Asian market.
 
Research and development costs rose 50 percent to $75 million from $50 million year over year.
 
Net income for the quarter dropped 19 percent to $44.6 million from $55.2 million in the prior-year period.
 
As of June 30, Beckman Coulter had $59.4 million in cash and cash equivalents.
 
Beckman CEO Scott Garrett said that  the "revenues in the Far East were disappointing due to a combination of factors” including slower-than-expected transition to a direct sales model in China and the fact that “hospitals are delaying purchases due to an expanding Chinese government review of overall hospital buying practices.”
 
Garrett said that Beckman expects to be “back on track with [its] double-digit growth trend” by the beginning of 2007.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.